Abstract Details

Title Outcomes following natalizumab exposure throughout pregnancy in patients with relapsing multiple sclerosis (RMS) or Crohn’s disease

Topic Multiple Sclerosis

Presentation(s) P1 - (-)

Poster/Presentation
Number 362

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Susan Friend (Biogen Idec) PRESENTER	No disclosure on file
	No disclosure on file
Denise I. Campagnolo, MD, MS	Dr. Campagnolo has received personal compensation for serving as an employee of Biogen. Dr. Campagnolo has received stock or an ownership interest from Biogen.
Lily Lee, PhD	Dr. Lee has nothing to disclose.

��ɫ��